相关实验视频

Updated: Jun 5, 2025

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes

Published on: March 15, 2018

[对胰岛素抵抗和肺癌临床相关机制的研究进展]

Xiaoyu Chen¹, Peng Chen¹

¹Department of Thoracic Oncology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.

Zhongguo fei ai za zhi = Chinese journal of lung cancer

|December 4, 2024

概括

胰岛素耐药性 (IR) 与肺癌的发展,进展和耐药性有关. 了解这种联系可能会导致肺癌的新诊断工具和治疗方法.

科学领域:

在瘤学瘤学.
内分泌学在内分泌学.
分子生物学分子生物学

背景情况:

全球肺癌的发病率和死亡率很高.
早期诊断,有效治疗和克服耐药性仍然是肺癌管理的重大挑战.
胰岛素抵抗 (IR) 是一种胰岛素作用受损的情况,与各种癌症越来越相关.

研究的目的:

探索胰岛素抵抗和肺癌之间的复杂关系.
阐明IR对肺癌发展,进展和治疗耐药性的影响和潜在机制.
确定肺癌潜在的新生物标志物和治疗点.

主要方法:

文献综述侧重于研究胰岛素抵抗和肺癌的研究.
分析胰岛素/胰岛素类生长因子信号通路的作用.
检查将IR与肺癌发生,进展和耐药性的证据.

主要成果:

越来越多的证据表明,胰岛素抵抗与肺癌的发病率和进展之间存在显著的关联.
胰岛素/胰岛素类生长因子信号通路被认为是这种关系中的关键调解者.
胰岛素耐药性可能会影响肺癌治疗的有效性,并导致耐药性.

结论:

胰岛素抵抗是肺癌病原和进展的关键因素.
准胰岛素信号通路可能为肺癌提供新的治疗策略.
对IR的进一步研究可能会产生新的预测生物标志物和治疗方法,以减少肺癌负担.

关键词:

药物耐药性药物耐药性药物耐药性胰岛素耐药性胰岛素耐药性是一种胰岛素样生长因子1受体肺部瘤是什么肺部瘤

更多相关视频

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

相关概念视频

Insulin: The Receptor and Signaling Pathways

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...